Lehrstuhl für Innere Medizin IV

Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial (2022) Bloch M, Kirtane A, Mahfoud F, Azizi M, Basile J, Daemen J, Saxena M, et al. Conference contribution Influence of Gender on Blood Pressure Reduction After Renal Denervation in GSR DEFINE (2022) Weil J, Mahfoud F, Schmieder R, Narkiewicz K, Williams B, Fahy M, Mancia G Conference contribution Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study (2022) Popp B, Ekici AB, Knaup K, Schneider K, Uebe S, Park J, Bafna V, et al. Journal article Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry (2022) Schmieder R, Mahfoud F, Mancia G, Narkiewicz K, Ruilope L, Hutton D, Cao K, et al. Journal article Treatment effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people underrepresented from the ontarget trial: Analysis of routinely collected data using trial replication methods (2022) Baptiste PJ, Wong A, Schultze A, Cunnington M, Mann J, Clase C, Leyrat C, et al. Conference contribution Detecting tandem repeat variants in coding regions using code-adVNTR (2022) Park J, Bakhtiari M, Popp B, Wiesener M, Bafna V Journal article An intermediate-effect size variant in UMOD confers risk for chronic kidney disease (2022) Olinger E, Schaeffer C, Kidd K, Elhassan EA, Cheng Y, Dufour I, Schiano G, et al. Journal article HIGH CHOLESTEROL ABSORPTION IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK IN HEMODIALYSIS PATIENTS: INSIGHTS FROM THE AURORA STUDY (2022) Silbernagel G, Duarte K, Sadiku S, Fauler G, Maerz W, Schmieder R, Jardine AG, et al. Conference contribution Evaluation of Morphological Changes in Retinal Vessels in Type 1 Diabetes Mellitus Patients with the Use of Adaptive Optics (2022) Matuszewski W, Gontarz-Nowak K, Harazny J, Bandurska-Stankiewicz E Journal article Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study (2022) Kolwelter J, Striepe K, Bosch A, Kannenkeril D, Ott C, Schiffer M, Schmieder R Journal article